Published in J Atr Fibrillation on August 31, 2015
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
A potential decline in life expectancy in the United States in the 21st century. N Engl J Med (2005) 19.63
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord (1998) 11.96
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Adiposity of the heart, revisited. Ann Intern Med (2006) 4.60
Impact of obesity on plasma natriuretic peptide levels. Circulation (2004) 4.46
Association of atrial fibrillation and obstructive sleep apnea. Circulation (2004) 3.81
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) (2010) 3.17
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol (2006) 3.11
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
The endotoxin-lipoprotein hypothesis. Lancet (2000) 3.03
Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol (2007) 2.99
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med (2005) 2.84
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol (1977) 2.45
Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med (2006) 2.45
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol (2007) 2.41
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (2003) 2.10
The obesity paradox in patients with peripheral arterial disease. Chest (2008) 2.09
Blood pressure in Canadian adults. Health Rep (2010) 1.93
Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol (2003) 1.79
Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol (1999) 1.62
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace (2006) 1.60
Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol (2010) 1.50
Obesity and cardiovascular disease. Curr Atheroscler Rep (2002) 1.36
Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J (2008) 1.30
Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol (2000) 1.28
Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol (2007) 1.24
Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.14
Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med (2010) 1.10
Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol (2001) 1.07
Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J (2008) 1.05
Predictors of weight change in overweight patients with myocardial infarction. Am Heart J (2007) 1.01
The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br J Clin Pharmacol (2008) 1.01
"Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J (2011) 0.97
Catheter ablation for atrial fibrillation in patients with obesity. Circulation (2008) 0.91
Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci (2007) 0.89
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J (2006) 0.89
Left ventricular filling pattern in uncomplicated obesity. Am J Cardiol (1996) 0.86
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension. Hypertension (1999) 0.84
Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease. Nutr Metab Cardiovasc Dis (2009) 0.83
Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease. Am J Cardiol (2012) 0.81
Obesity paradox in patients with atrial fibrillation and heart failure. Int J Cardiol (2014) 0.79
Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results. J Atr Fibrillation (2014) 0.76